Cargando…
Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study
BACKGROUND AND PURPOSE: Nicergoline is an ergoline derivative that is used to treat cognitive deficits in cerebrovascular disease and various forms of dementia. Although therapeutic effects of nicergoline have been established, little is known about its effects on cerebral perfusion in Alzheimer...
Autores principales: | Im, Jooyeon J., Jeong, Hyeonseok S., Park, Jong-Sik, Yang, YoungSoon, Na, Seung-Hee, Oh, Jin Kyoung, Chung, Yong-An, Song, In-Uk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dementia Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428003/ https://www.ncbi.nlm.nih.gov/pubmed/30906380 http://dx.doi.org/10.12779/dnd.2017.16.4.104 |
Ejemplares similares
-
Associations between Brain Perfusion and Sleep Disturbance in Patients with Alzheimer's Disease
por: Im, Jooyeon J., et al.
Publicado: (2017) -
Brain Perfusion Correlates of Apathy in Alzheimer's Disease
por: Jeong, Hyeonseok, et al.
Publicado: (2018) -
Cerebral Perfusion Changes after Acetyl-L-Carnitine Treatment in Early Alzheimer's Disease Using Single Photon Emission Computed Tomography
por: Jeong, Hyeonseok S., et al.
Publicado: (2017) -
Longitudinal Cerebral Perfusion Changes in Parkinson's Disease with Subjective Cognitive Impairment
por: Jeong, Hyeonseok S., et al.
Publicado: (2016) -
A pilot clinical study of low-intensity transcranial focused ultrasound in Alzheimer’s disease
por: Jeong, Hyeonseok, et al.
Publicado: (2021)